Effectiveness of a third dose of the BNT162b2 mRNA COVID-19 vaccine for preventing severe outcomes in Israel: an observational study

Diferencias entre dos y tres dosis frente a ingresos

https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(21)02249-2/fulltext